TY - JOUR T1 - 8th European Conference on Clinical Aspects and Treatment of HIV Infection, Athens, 28–31 October 2001 JF - Sexually Transmitted Infections JO - Sex Transm Infect SP - 149 LP - 149 DO - 10.1136/sti.78.2.149 VL - 78 IS - 2 AU - Adrian Palfreeman AU - Mia Huengsberg Y1 - 2002/04/01 UR - http://sti.bmj.com/content/78/2/149.abstract N2 - The conference was set in the Astir Hotel Resort on the peninsula at the outskirts of Athens, overlooking the Phaleron Bay. It was officially opened by Dr Christine Katlama, president of the European AIDS Clinical Society, and Professor John Kosmidis, the conference chairman. The European Clinical Guidelines for HIV management, written by the European AIDS Clinical Society (EACS), was launched at the conference.The main focus of many delegates was on new antiretroviral drugs. The star of the conference was tenofovir disoproxil fumarate, a single tablet, once daily nucleotide developed by Gilead Sciences. It has potent activity against multidrug nucleoside resistant HIV, with the exception of T69 insertion, which is fortunately rare (1% of all patients). At 24 weeks, adding tenofovir … ER -